טוען...
Targeting the COX-2 Pathway to Improve Therapeutic Response in the Obese Breast Cancer Patient Population
Multiple studies have demonstrated that obesity is associated with a worse outcome for all breast cancer subtypes and that obese breast cancer patients do not respond as well as normal weight patients to aromatase inhibitor treatment and chemotherapy. While a number of mechanisms have been proposed...
שמור ב:
| הוצא לאור ב: | Curr Pharmacol Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591549/ https://ncbi.nlm.nih.gov/pubmed/26442202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-015-0041-y |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|